Post-Operative Voiding After Gynecological Surgery Trial (POVAGS)

August 16, 2020 updated by: Jonathon Solnik, Women's College Hospital

Post-Operative Voiding After Gynecological Surgery (POVAGS) Trial: a Randomized Controlled Trial on Retrograde Bladder Filling After Outpatient Gynaecological Laparoscopy

To determine whether partially filling the bladder after outpatient gynaecological laparoscopy expedites time to first void and discharge. Methods: A single site, single-blinded, randomized control trial in which eligible patients undergo partial retrograde bladder filling immediately post-operatively compared to bladder drainage and foley catheter removal. Primary outcome is time to first void, secondary outcomes include time to discharge, post-operative complications and patient satisfaction.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 1B2
        • Women's College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women
  • Undergoing elective laparoscopy for a gynaecological indication
  • Plan for same day discharge
  • Able to provide informed consent

Exclusion Criteria:

  • Pregnancy
  • Undergoing procedure for pelvic organ prolapse, stress urinary incontinence, or nerve detrapment
  • Prior hysterectomy, or incontinence/pelvic organ prolapse procedures
  • Pre-existing voiding dysfunction
  • Known recurrent urinary tract infections
  • Known genito-urinary malformations
  • Known for neuromuscular disorders such as multiple sclerosis
  • Use of anticholinergic medication
  • Intraoperative bladder related complications
  • Need for discharge with indwelling foley catheter
  • Patients requiring overnight admission for any reason

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Retrograde filled
This arm will contain patients who had retrograde bladder filling upon completion of surgery with 200 milliliters (mL) of sterile saline.
The bladder will be filled with a large syringe through the urinary catheter (which is left in place for the surgery) with 200mL of sterile saline, and then the catheter will be removed.
NO_INTERVENTION: Control
This arm will contain patients who simply had the urinary catheter removed upon completion of surgery, and were left with an empty bladder.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to first void
Time Frame: 3 hours
Time in minutes from arrival in post-operative anesthesia unit (PACU) to first void
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to discharge
Time Frame: 8 hours
Time in minutes from arrival in PACU to discharge from PACU
8 hours
Post-operative complications
Time Frame: 1 week following surgery
Urinary tract infections, or other reported complications
1 week following surgery
Patient satisfaction
Time Frame: 1 week
Patients' subjective experience in both groups regarding time spent in PACU and first postoperative week
1 week
Post-operative pain
Time Frame: Assessed at the 1 hour mark
visual analogue scale of postoperative pain, assessed in PACU
Assessed at the 1 hour mark

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ally Murji, MD, Women's College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 10, 2020

Primary Completion (ACTUAL)

April 27, 2020

Study Completion (ACTUAL)

April 27, 2020

Study Registration Dates

First Submitted

December 12, 2019

First Submitted That Met QC Criteria

December 12, 2019

First Posted (ACTUAL)

December 13, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 18, 2020

Last Update Submitted That Met QC Criteria

August 16, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Retrograde bladder filling

3
Subscribe